# A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

> **NCT06840691** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 87 (estimated)

## Conditions studied

- Pediatric Growth Hormone Deficiency (PGHD)

## Interventions

- **DRUG:** PEG-rhGH with new preparation (T)
- **DRUG:** PEG-rhGH with present preparation (T)

## Key facts

- **NCT ID:** NCT06840691
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2025-05
- **Final completion:** 2025-09
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06840691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06840691, "A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06840691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*